Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Control Intervention1: Nil: Nil
Sponsors
Kalinga Institute of Medical Sciences KIMS Regional Medical Research Center ICMR Bhubaneswar
Eligibility
Inclusion criteria
Inclusion criteria: 1. Relative of patient being included in the study, preferably staying the same household. 2. No known rheumatic diseases
Exclusion criteria
Exclusion criteria: 1. Acquired immunodeficiency syndrome 2. Any active infection as indicated by patient being on systemic antibiotics, anti-fungals or anti-mycobacterial chemotherapy 3. Pregnancy , chronic renal failure , chronic liver disease, diabetes mellitus 4. Any known malignancy or has received chemotherapy in the last six months 5. Patients who have received plasma therapy (for COVID-19)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of antibody levelTimepoint: 4 months (2 months sample collection, 1 month lab analysis, 1 month manuscript preparation) | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NA | — |
Countries
India
Contacts
Public ContactRamnath Misra
Kalinga Institute of Medical sciences, KIIT University
Outcome results
None listed